| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PLoSO...876804L |
| P356 | DOI | 10.1371/JOURNAL.PONE.0076804 |
| P932 | PMC publication ID | 3788738 |
| P698 | PubMed publication ID | 24098563 |
| P5875 | ResearchGate publication ID | 257464863 |
| P2093 | author name string | Robert J Hogan | |
| Eric R Lafontaine | |||
| Frank Michel | |||
| Shawn M Zimmerman | |||
| Xiudan Gao | |||
| Teresa L Shaffer | |||
| P2860 | cites work | The early stage of bacterial genome-reductive evolution in the host | Q21131555 |
| Structural flexibility in the Burkholderia mallei genome | Q22066378 | ||
| Melioidosis: epidemiology, pathophysiology, and management | Q24522461 | ||
| Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei | Q24564168 | ||
| Glanders in a military research microbiologist | Q28209215 | ||
| Glanders: off to the races with Burkholderia mallei | Q28258357 | ||
| First shots fired in biological warfare | Q28283565 | ||
| Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis | Q28284436 | ||
| Strategies toward vaccines against Burkholderia mallei and Burkholderia pseudomallei | Q28299584 | ||
| Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei | Q28302368 | ||
| Optimisation of bioluminescent reporters for use with mycobacteria | Q28474040 | ||
| Pulmonary microbial infection in mice: comparison of different application methods and correlation of bacterial numbers and histopathology. | Q51705179 | ||
| Melioidosis | Q56286799 | ||
| Burkholderia pseudomallei aerosol infection results in differential inflammatory responses in BALB/c and C57Bl/6 mice | Q56766784 | ||
| Structure of the polysaccharide chains of Pseudomonas pseudomallei lipopolysaccharides | Q67464506 | ||
| Equine glanders in Turkey | Q77345255 | ||
| Non-invasive pulmonary aerosol delivery in mice by the endotracheal route | Q80415727 | ||
| Relationship between antigenicity and pathogenicity for Burkholderia pseudomallei and Burkholderia mallei revealed by a large panel of mouse MAbs | Q81791666 | ||
| Polysaccharide microarray technology for the detection of Burkholderia pseudomallei and Burkholderia mallei antibodies | Q83963244 | ||
| Melioidosis | Q84964739 | ||
| Trimethoprim/sulfamethoxazole (co-trimoxazole) prophylaxis is effective against acute murine inhalational melioidosis and glanders. | Q38893860 | ||
| The utility of a nebulised intra-tracheal rat model of invasive pulmonary aspergillosis | Q38938053 | ||
| Melioidosis: acute and chronic disease, relapse and re-activation | Q38958161 | ||
| Isolation of polymyxin B-susceptible mutants of Burkholderia pseudomallei and molecular characterization of genetic loci involved in polymyxin B resistance. | Q39472156 | ||
| High-level resistance to fluoroquinolones and cephalosporins in Burkholderia pseudomallei and closely related species | Q41440467 | ||
| Moraxella catarrhalis strain O35E expresses two filamentous hemagglutinin-like proteins that mediate adherence to human epithelial cells | Q42029171 | ||
| Aerogenic vaccination with a Burkholderia mallei auxotroph protects against aerosol-initiated glanders in mice. | Q43218668 | ||
| Fusion of human neutrophil phagosomes with lysosomes in vitro: involvement of tyrosine kinases of the Src family and inhibition by mycobacteria | Q43681974 | ||
| Antigenic relatedness between Burkholderia pseudomallei and Burkholderia mallei | Q43991751 | ||
| Burkholderia pseudomallei: animal models of infection | Q44023136 | ||
| Glanders--a potential disease for biological warfare in humans and animals | Q44096540 | ||
| Nasal-associated lymphoid tissue and olfactory epithelium as portals of entry for Burkholderia pseudomallei in murine melioidosis | Q44393273 | ||
| The type II O-antigenic polysaccharide moiety of Burkholderia pseudomallei lipopolysaccharide is required for serum resistance and virulence | Q44760968 | ||
| Epidemiologic studies of latent virus infections in captive monkeys and baboons. II. Serologic evidence of myxovirus infections with special reference to SV5. | Q44824069 | ||
| Application of carbohydrate microarray technology for the detection of Burkholderia pseudomallei, Bacillus anthracis and Francisella tularensis antibodies. | Q46536685 | ||
| Direct visual instillation as a method for efficient delivery of fluid into the distal airspaces of anesthetized mice | Q46632727 | ||
| Experimental aerogenic Burkholderia mallei (glanders) infection in the BALB/c mouse | Q48147368 | ||
| Experimental acute respiratory Burkholderia pseudomallei infection in BALB/c mice. | Q48762344 | ||
| The Moraxella catarrhalis autotransporter McaP is a conserved surface protein that mediates adherence to human epithelial cells through its N-terminal passenger domain | Q30159574 | ||
| Detection of bacterial virulence genes by subtractive hybridization: identification of capsular polysaccharide of Burkholderia pseudomallei as a major virulence determinant | Q30635403 | ||
| Burkholderia Hep_Hag autotransporter (BuHA) proteins elicit a strong antibody response during experimental glanders but not human melioidosis | Q33278807 | ||
| Comparison of the in vitro and in vivo susceptibilities of Burkholderia mallei to Ceftazidime and Levofloxacin. | Q33441941 | ||
| Identification of Burkholderia mallei and Burkholderia pseudomallei adhesins for human respiratory epithelial cells | Q33709714 | ||
| Melioidosis as an emerging global problem | Q33837713 | ||
| Critical protective role for MCP-1 in pneumonic Burkholderia mallei infection | Q33886336 | ||
| Burkholderia mallei cellular interactions in a respiratory cell model. | Q33920455 | ||
| Rat respiratory coronavirus infection: replication in airway and alveolar epithelial cells and the innate immune response | Q33920480 | ||
| Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature | Q33922796 | ||
| Genomic acquisition of a capsular polysaccharide virulence cluster by non-pathogenic Burkholderia isolates | Q34156158 | ||
| Identification of a Burkholderia mallei polysaccharide gene cluster by subtractive hybridization and demonstration that the encoded capsule is an essential virulence determinant | Q34515336 | ||
| Biodefense-driven murine model of pneumonic melioidosis | Q34532156 | ||
| Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents | Q34552243 | ||
| Evaluation of surrogate animal models of melioidosis | Q35028834 | ||
| Bioluminescent diagnostic imaging to characterize altered respiratory tract colonization by the burkholderia pseudomallei capsule mutant | Q35054924 | ||
| A novel respiratory model of infection with monkeypox virus in cynomolgus macaques. | Q35076685 | ||
| In vivo Bioluminescence Imaging of Burkholderia mallei Respiratory Infection and Treatment in the Mouse Model | Q35182600 | ||
| Structural characterization of the lipopolysaccharide O antigens of Burkholderia pseudomallei. | Q35434806 | ||
| Specificity and functional activity of anti-Burkholderia pseudomallei polysaccharide antibodies | Q35554658 | ||
| Mutagenesis of Burkholderia pseudomallei with Tn5-OT182: isolation of motility mutants and molecular characterization of the flagellin structural gene | Q35621322 | ||
| Passive protection of diabetic rats with antisera specific for the polysaccharide portion of the lipopolysaccharide isolated from Pseudomonas pseudomallei | Q35650030 | ||
| MyD88-dependent recruitment of monocytes and dendritic cells required for protection from pulmonary Burkholderia mallei infection | Q35665376 | ||
| Melioidosis, northeastern Brazil | Q35847479 | ||
| Development of capsular polysaccharide-based glycoconjugates for immunization against melioidosis and glanders | Q36164961 | ||
| The nose revisited: a brief review of the comparative structure, function, and toxicologic pathology of the nasal epithelium | Q36477891 | ||
| A non-invasive intratracheal inoculation method for the study of pulmonary melioidosis | Q36479077 | ||
| Workshop on treatment of and postexposure prophylaxis for Burkholderia pseudomallei and B. mallei Infection, 2010 | Q36570592 | ||
| Virulence of Burkholderia mallei quorum-sensing mutants | Q36826958 | ||
| Protection from pneumonic infection with burkholderia species by inhalational immunotherapy | Q37145069 | ||
| A Burkholderia pseudomallei protein microarray reveals serodiagnostic and cross-reactive antigens | Q37278865 | ||
| Immunity to Burkholderia pseudomallei | Q37412120 | ||
| The molecular and cellular basis of pathogenesis in melioidosis: how does Burkholderia pseudomallei cause disease? | Q37592283 | ||
| Deficiency of XIAP leads to sensitization for Chlamydophila pneumoniae pulmonary infection and dysregulation of innate immune response in mice | Q37853175 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Burkholderia mallei | Q134434 |
| Burkholderia pseudomallei | Q140475 | ||
| reproducibility | Q1425625 | ||
| P304 | page(s) | e76804 | |
| P577 | publication date | 2013-10-02 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Use of a safe, reproducible, and rapid aerosol delivery method to study infection by Burkholderia pseudomallei and Burkholderia mallei in mice | |
| P478 | volume | 8 |
| Q60922208 | Antibodies Are Major Drivers of Protection against Lethal Aerosol Infection with Highly Pathogenic spp |
| Q38784773 | Antibodies against In Vivo-Expressed Antigens Are Sufficient To Protect against Lethal Aerosol Infection with Burkholderia mallei and Burkholderia pseudomallei |
| Q33611911 | Characterization of an autotransporter adhesin protein shared by Burkholderia mallei and Burkholderia pseudomallei |
| Q64064783 | Characterization of an intratracheal aerosol challenge model of Brucella melitensis in guinea pigs |
| Q36289996 | Characterization of pathogenesis of and immune response to Burkholderia pseudomallei K96243 using both inhalational and intraperitoneal infection models in BALB/c and C57BL/6 mice |
| Q37623675 | Comparative Burkholderia pseudomallei natural history virulence studies using an aerosol murine model of infection. |
| Q35563740 | Complete genome sequences for 59 burkholderia isolates, both pathogenic and near neighbor |
| Q90001184 | Coxiella burnetii Intratracheal Aerosol Infection Model in Mice, Guinea Pigs, and Nonhuman Primates |
| Q92076410 | Dose-dependant acute or subacute disease caused by Burkholderia pseudomallei strain NCTC 13392 in a BALB/c aerosol model of infection |
| Q34682080 | Oropharyngeal aspiration of Burkholderia mallei and Burkholderia pseudomallei in BALB/c mice |
| Q35242077 | Systematic mutagenesis of genes encoding predicted autotransported proteins of Burkholderia pseudomallei identifies factors mediating virulence in mice, net intracellular replication and a novel protein conferring serum resistance |
| Q27307715 | The Autotransporter BpaB Contributes to the Virulence of Burkholderia mallei in an Aerosol Model of Infection |
| Q94568361 | The autotransporter protein BatA is a protective antigen against lethal aerosol infection with and |
| Q47395188 | Use of Immunohistochemistry to Demonstrate In Vivo Expression of the Burkholderia mallei Virulence Factor BpaB During Experimental Glanders. |
| Q35364578 | Use of the common marmoset to study Burkholderia mallei infection |
| Q49834322 | Vaccines for the Prevention of Melioidosis and Glanders. |
Search more.